Emergent BioSolutions (EBS) Acquisitions (2013 - 2015)

Emergent BioSolutions' Acquisitions history runs 3 years deep, the most recent figure standing at $650000.0 for Q4 2015.

• In Q4 2015, Acquisitions fell 46.37% year-over-year to $650000.0; the TTM figure through Dec 2016 stood at $650000.0 (changed 0.0% YoY), while the FY2018 annual figure was $827.7 million, up 604.43% from the prior year.
• Acquisitions was $650000.0 for Q4 2015 at Emergent BioSolutions, down from $1.2 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $178.2 million in Q1 2014 to a low of $650000.0 in Q4 2015.
• Historically, Acquisitions has averaged $51.5 million across 3 years, with a median of $13.5 million in 2013.
• The sharpest annual moves came in 2014 and 2015: Acquisitions sank 95.32% in 2014, then tumbled 46.37% in 2015.
• A 3-year view of Acquisitions shows it stood at $25.9 million in 2013, then tumbled by 95.32% to $1.2 million in 2014, then sank by 46.37% to $650000.0 in 2015.
• The last three Acquisitions figures came in at $650000.0 (Q4 2015), $1.2 million (Q4 2014), and $178.2 million (Q1 2014), per Business Quant data.